tiprankstipranks
Iperionx Limited (AU:IPX)
ASX:IPX

Iperionx Limited (IPX) AI Stock Analysis

Compare
148 Followers

Top Page

AU:IPX

Iperionx Limited

(Sydney:IPX)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
AU$3.00
â–¼(-51.46% Downside)
Action:ReiteratedDate:03/24/26
The score is held down primarily by weak financial performance (no revenue, large and expanding losses, and heavy cash burn) and a bearish technical trend with negative momentum. A relatively strong balance sheet with low leverage provides some support, but the negative P/E and lack of dividend reinforce the higher-risk profile.
Positive Factors
Proprietary low-energy titanium processing
Owning proprietary processing that lowers cost, energy use and emissions is a durable competitive asset. It can meaningfully reduce unit economics, support margin improvement once commercialized, and create barriers to entry for rivals while aligning with long-term decarbonization and procurement trends.
Negative Factors
Pre-revenue company with no sales history
Being pre-revenue is a material execution risk: there's no demonstrated ability to convert technology into paying customers. This prolongs dependency on external funding and means commercial viability, pricing power and sustainable margins remain unproven over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary low-energy titanium processing
Owning proprietary processing that lowers cost, energy use and emissions is a durable competitive asset. It can meaningfully reduce unit economics, support margin improvement once commercialized, and create barriers to entry for rivals while aligning with long-term decarbonization and procurement trends.
Read all positive factors

Iperionx Limited (IPX) vs. iShares MSCI Australia ETF (EWA)

Iperionx Limited Business Overview & Revenue Model

Company Description
IperionX Limited focuses on the development of low carbon titanium for space, aerospace, electric vehicles, and 3D printing industries. The company also produces titanium metal powders from titanium scrap at its operational pilot facility in Utah....
How the Company Makes Money
null...

Iperionx Limited Financial Statement Overview

Summary
Overall financial quality is weak: the company remains pre-revenue with materially widening losses (FY2025 net loss ~-35.3m; EBIT ~-38.3m) and significant cash burn (FY2025 operating cash flow ~-21.8m; free cash flow ~-39.4m). The main offset is a comparatively solid balance sheet with low leverage (debt-to-equity ~0.04) and sizable equity (~92.4m), though ongoing losses raise funding/dilution risk.
Income Statement
12
Very Negative
Balance Sheet
68
Positive
Cash Flow
18
Very Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue0.000.000.000.000.000.00
Gross Profit0.000.00-657.16K-634.11K-211.58K-9.38K
EBITDA-35.31M-37.79M-22.49M-17.48M-29.39M-8.82M
Net Income-35.43M-35.35M-22.23M-25.93M-21.52M-14.43M
Balance Sheet
Total Assets129.24M105.03M55.44M22.80M9.91M2.79M
Cash, Cash Equivalents and Short-Term Investments65.87M54.81M33.16M11.94M5.67M1.70M
Total Debt4.46M3.93M1.49M975.31K543.03K475.65K
Total Liabilities20.97M12.59M4.10M2.24M2.49M762.50K
Stockholders Equity108.27M92.44M51.34M20.56M7.42M1.76M
Cash Flow
Free Cash Flow-14.24M-39.41M-26.68M-18.57M-14.06M-3.62M
Operating Cash Flow-8.89M-21.80M-18.61M-15.86M-12.13M-3.56M
Investing Cash Flow-5.62M-24.28M-6.53M-5.71M-3.07M1.76M
Financing Cash Flow855.79K67.99M46.59M27.89M19.39M3.50M

Iperionx Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.18
Price Trends
50DMA
6.25
Negative
100DMA
5.88
Negative
200DMA
6.07
Negative
Market Momentum
MACD
-0.81
Positive
RSI
27.41
Positive
STOCH
2.60
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IPX, the sentiment is Negative. The current price of 6.18 is above the 20-day moving average (MA) of 5.63, below the 50-day MA of 6.25, and above the 200-day MA of 6.07, indicating a bearish trend. The MACD of -0.81 indicates Positive momentum. The RSI at 27.41 is Positive, neither overbought nor oversold. The STOCH value of 2.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:IPX.

Iperionx Limited Risk Analysis

Iperionx Limited disclosed 51 risk factors in its most recent earnings report. Iperionx Limited reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Iperionx Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
46
Neutral
AU$362.01M-3.97-12.76%――51.47%
45
Neutral
AU$164.17M-5.58-8.25%――-55.56%
43
Neutral
AU$1.16B-8.87-35.30%――-20.85%
43
Neutral
AU$278.39M-15.09-26.32%――-91.89%
42
Neutral
AU$798.54M-9.79-18.49%―620.73%-21.19%
41
Neutral
AU$191.08M55.210.70%1.54%14.64%-213.25%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:IPX
Iperionx Limited
3.43
0.25
7.86%
AU:AGE
Alligator Energy Ltd
0.04
<0.01
8.82%
AU:OMH
OM Holdings Ltd.
0.25
-0.09
-25.37%
AU:LOT
Lotus Resources Limited
1.33
-0.69
-34.15%
AU:CAY
Canyon Resources Limited
0.14
-0.08
-38.64%
AU:A4N
Alpha HPA Limited
0.55
-0.28
-34.13%

Iperionx Limited Corporate Events

IperionX Shareholders Approve Director Equity Incentives at General Meeting
Mar 19, 2026
IperionX Limited reported the outcomes of its March 19, 2026 General Meeting of shareholders, where all resolutions put forward were carried by poll. The meeting followed procedures under Australian corporate and listing rules, underscoring the co...
IperionX denies undisclosed news behind share slump, details U.S. grant funding
Mar 16, 2026
IperionX Limited has responded to an ASX price query following a sharp fall in its share price from A$6.93 on 12 March 2026 to an intraday low of A$4.58 on 16 March 2026. The company stated it is not aware of any undisclosed information that could...
IperionX Issues New Fully Paid Shares Under Australian Disclosure Exemption
Feb 24, 2026
IperionX Limited has issued 1,288,179 fully paid ordinary shares, adding to its existing class of securities quoted on the Australian Securities Exchange. The company confirmed the shares were issued without a prospectus under Australian corporati...
Iperionx Seeks ASX Quotation for New Equity Issued in Lieu of Cash
Feb 23, 2026
Iperionx Limited has applied to the ASX for quotation of 1,273,179 ordinary fully paid shares under its IPX code, with an issue date of February 24, 2026. The shares are being issued in lieu of a cash settlement, indicating the company has chosen ...
IperionX Issues Shares in Cashless Settlement Deal
Feb 23, 2026
IperionX Limited is a dual-listed company with ordinary shares traded on the ASX and ADSs on Nasdaq under the symbol IPX, providing investors access to its equity through both Australian and U.S. markets. The company&#8217;s share pricing reflects...
IperionX Director Trims Shareholding in Routine Tax-Related Sale
Feb 9, 2026
IperionX Limited has reported a change in director Vaughn Taylor&#8217;s indirect interest in the company&#8217;s securities, following an on-market sale of 150,000 fully paid ordinary shares by Nalaroo Holdings Pty Ltd, a related entity. The sale...
IperionX Names New Company Secretary and Shifts Corporate Base to Sydney CBD
Feb 9, 2026
IperionX Limited has appointed Louisa Martino as Company Secretary, effective February 16, 2026, bringing more than 15 years of company secretarial and corporate advisory experience, including work on corporate compliance, capital raisings and due...
IperionX Director Increases Shareholding Through RSU Conversion
Feb 3, 2026
IperionX Limited has disclosed a change in the equity interests held by director Todd Hannigan, following the vesting of part of his share-based remuneration. The director converted 159,333 restricted stock units into an equivalent number of ordin...
IperionX Issues 1.77 Million New Shares on ASX
Feb 3, 2026
IperionX Limited has issued 1,773,212 fully paid ordinary shares that form part of its existing class of securities quoted on the Australian Securities Exchange. The company confirmed that the issuance was conducted without a disclosure document u...
Iperionx Seeks ASX Quotation for 1.77 Million New Shares
Feb 3, 2026
Iperionx Limited has applied to the ASX for quotation of 1,773,212 new ordinary fully paid shares under the code IPX, issued on 3 February 2026. The additional quoted securities will expand the company&#8217;s listed share capital, potentially enh...
IperionX Targets Low-Cost U.S. Titanium Leadership With Virginia Expansion
Feb 1, 2026
IperionX Limited says it is entering 2026 in a strong operational position as it scales commercial production of titanium at its Virginia Titanium Campus, aiming to re-shore and become the world&#8217;s lowest-cost producer of high-performance tit...
IperionX Ramps Up U.S. Titanium Manufacturing as Government-Backed Expansion Gathers Pace
Jan 30, 2026
IperionX Limited reported that it has fully commissioned titanium powder and component manufacturing at its Virginia Titanium Manufacturing Campus and is expanding capacity with new presses, ISO 9001-certified quality systems and inventory build-u...
IperionX Wins Prototype Order to Supply Recycled Titanium Parts for U.S. Army Combat Vehicles
Jan 21, 2026
IperionX has secured a US$300,000 prototype purchase order from American Rheinmetall to produce 700 lightweight titanium components for U.S. Army heavy ground combat systems, with delivery expected within eight to nine months and the potential to ...
IperionX Secures Final US$4.6m in U.S. Funding and Free Titanium Scrap for Virginia Expansion
Jan 15, 2026
IperionX Limited has received the final US$4.6 million tranche of a US$47.1 million award from the U.S. Department of War&#8217;s Industrial Base Analysis and Sustainment program, funding the scale-up of titanium production and advanced manufactur...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026